Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Deficiency of IκB Kinase β in Myeloid Cells Reduces Severity of Experimental Autoimmune Encephalomyelitis.
Glial cell biology in the Great Lakes region.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Embryonic stem cells in multiple sclerosis.
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Oligodendrogenesis in the normal and pathological central nervous system.
Simvastatin in patients with progressive multiple sclerosis.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.
Integrative therapies for multiple sclerosis.
Culturing microglia from the neonatal and adult central nervous system.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.
Proteinticle Engineering for Accurate 3D Diagnosis.
Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
P wave duration and dispersion and QT interval in multiple sclerosis.
Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Pages
« first
‹ previous
…
399
400
401
402
403
404
405
406
407
…
next ›
last »